Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response

Understanding how the immune system decides between tolerance and activation by antigens requires addressing cytokine regulation as a highly dynamic process. We quantified the dynamics of interleukin‐2 (IL‐2) signaling in a population of T cells during an immune response by combining in silico modeling and single‐cell measurements in vitro. We demonstrate that IL‐2 receptor expression levels vary widely among T cells creating a large variability in the ability of the individual cells to consume, produce and participate in IL‐2 signaling within the population. Our model reveals that at the population level, these heterogeneous cells are engaged in a tug‐of‐war for IL‐2 between regulatory (Treg) and effector (Teff) T cells, whereby access to IL‐2 can either increase the survival of Teff cells or the suppressive capacity of Treg cells. This tug‐of‐war is the mechanism enforcing, at the systems level, a core function of Treg cells, namely the specific suppression of survival signals for weakly activated Teff cells but not for strongly activated cells. Our integrated model yields quantitative, experimentally validated predictions for the manipulation of Treg suppression.

[1]  J. Economou,et al.  Lymphocyte-activating factor. I. Generation and physicochemical characterization. , 1978, Journal of immunology.

[2]  H. Berg Random Walks in Biology , 2018 .

[3]  D. Cantrell,et al.  The interleukin-2 T-cell system: a new cell growth model. , 1984, Science.

[4]  D. Cantrell,et al.  Interleukin 2 regulates its own receptors. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Dautry‐Varsat,et al.  Receptor-mediated endocytosis of interleukin 2 in a human tumor T cell line. Degradation of interleukin 2 and evidence for the absence of recycling of interleukin receptors. , 1986, The Journal of biological chemistry.

[6]  P. Néve,et al.  Interleukin 2 , 1987, Acta clinica Belgica.

[7]  Kendall A. Smith,et al.  The interleukin 2 receptor. Functional consequences of its bimolecular structure , 1987, The Journal of experimental medicine.

[8]  Kendall A. Smith,et al.  Interleukin-2: inception, impact, and implications. , 1988, Science.

[9]  A. Dautry‐Varsat,et al.  Down-regulation of high affinity interleukin 2 receptors in a human tumor T cell line. Interleukin 2 increases the rate of surface receptor decay. , 1988, The Journal of biological chemistry.

[10]  M. Ferrer,et al.  Modulation of interleukin 2 internalization and interleukin 2-dependent cell growth by antireceptor antibodies. , 1991, The Journal of biological chemistry.

[11]  M. Lenardo lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis , 1991, Nature.

[12]  M. Lenardo Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. , 1991, Nature.

[13]  I. Horak,et al.  Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting , 1991, Nature.

[14]  T. Waldmann,et al.  The interleukin-2 receptor. , 1991, The Journal of biological chemistry.

[15]  W. Paul,et al.  The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice , 1992, The Journal of experimental medicine.

[16]  N. Tanaka,et al.  Cloning of the gamma chain of the human IL-2 receptor. , 1992, Science.

[17]  D A Lauffenburger,et al.  The role of low-affinity interleukin-2 receptors in autocrine ligand binding: alternative mechanisms for enhanced binding effect. , 1994, Molecular immunology.

[18]  H. Griesser,et al.  Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. , 1995, Science.

[19]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[20]  E Morelon,et al.  Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains , 1995, The Journal of cell biology.

[21]  F. Alt,et al.  Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.

[22]  Kendall A. Smith,et al.  Interleukin‐2 Deficient Mice: A New Model to Study Autoimmunity and Self‐Tolerance , 1995, Immunological reviews.

[23]  B. Goldstein,et al.  Solution Assembly of a Soluble, Heteromeric, High Affinity Interleukin-2 Receptor Complex (*) , 1995, The Journal of Biological Chemistry.

[24]  C. Janeway,et al.  Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Ethan M. Shevach,et al.  CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.

[26]  Z Reich,et al.  Ligand recognition by alpha beta T cell receptors. , 1998, Annual review of immunology.

[27]  M. Surette,et al.  Quorum sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer production. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  B. Goldstein,et al.  Solution assembly of the pseudo‐high affinity and intermediate affinity interleukin‐2 receptor complexes , 2008, Protein science : a publication of the Protein Society.

[29]  W. Leonard,et al.  The role of Stat5a and Stat5b in signaling by IL-2 family cytokines , 2000, Oncogene.

[30]  J. Ihle The Stat family in cytokine signaling. , 2001, Current opinion in cell biology.

[31]  C. Surh,et al.  Autologous Regulation of Naive T Cell Homeostasis Within the T Cell Compartment1 , 2001, The Journal of Immunology.

[32]  W. Leonard,et al.  The Basis for IL-2-Induced IL-2 Receptor α Chain Gene Regulation , 2001 .

[33]  W. Leonard,et al.  The basis for IL-2-induced IL-2 receptor alpha chain gene regulation: importance of two widely separated IL-2 response elements. , 2001, Immunity.

[34]  Y. Belkaid,et al.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.

[35]  Mark M. Davis,et al.  Direct observation of ligand recognition by T cells , 2002, Nature.

[36]  Byron Goldstein,et al.  Analysis of the role of the interleukin-2 receptor gamma chain in ligand binding. , 2002, Biochemistry.

[37]  J. Ellery,et al.  Alternate signalling pathways from the interleukin-2 receptor. , 2002, Cytokine & growth factor reviews.

[38]  A. Norment,et al.  High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell‐mediated suppression in vitro , 2003, European journal of immunology.

[39]  Ruslan Medzhitov,et al.  Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells , 2003, Science.

[40]  Mark M Davis,et al.  Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. , 2003, Molecular cell.

[41]  Stanislav Y Shvartsman,et al.  Stochastic model of autocrine and paracrine signals in cell culture assays. , 2003, Biophysical journal.

[42]  Ronald H. Schwartz,et al.  IL-2 Secretion by CD4+ T Cells In Vivo Is Rapid, Transient, and Influenced by TCR-Specific Competition , 2004, The Journal of Immunology.

[43]  S. Sakaguchi Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.

[44]  S. Rutz,et al.  Interleukin‐2 is essential for CD4+CD25+ regulatory T cell function , 2004, European journal of immunology.

[45]  William S. Hlavacek,et al.  BioNetGen: software for rule-based modeling of signal transduction based on the interactions of molecular domains , 2004, Bioinform..

[46]  S. Shvartsman,et al.  Ligand trapping in epithelial layers and cell cultures. , 2004, Biophysical chemistry.

[47]  Adrian Vella,et al.  Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. , 2005, American journal of human genetics.

[48]  M. Veldhoen,et al.  CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. , 2005, International immunology.

[49]  Ronald N Germain,et al.  Modeling T Cell Antigen Discrimination Based on Feedback Control of Digital ERK Responses , 2005, PLoS biology.

[50]  K. Christopher Garcia,et al.  The Structure of Interleukin-2 Complexed with Its Alpha Receptor , 2005, Science.

[51]  Angela Hughson,et al.  Early Kinetic Window of Target T Cell Susceptibility to CD25+ Regulatory T Cell Activity1 , 2005, The Journal of Immunology.

[52]  D. Gray,et al.  CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  K. Garcia,et al.  Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. , 2005, Science.

[54]  H. Boehmer,et al.  Mechanisms of suppression by suppressor T cells , 2005, Nature Immunology.

[55]  Garry P. Nolan,et al.  Coordinate Analysis of Murine Immune Cell Surface Markers and Intracellular Phosphoproteins by Flow Cytometry1 , 2005, The Journal of Immunology.

[56]  N. Burroughs,et al.  Regulatory T cell adjustment of quorum growth thresholds and the control of local immune responses. , 2006, Journal of theoretical biology.

[57]  A. Adler,et al.  Cutting Edge: Paracrine, but Not Autocrine, IL-2 Signaling Is Sustained during Early Antiviral CD4 T Cell Response1 , 2006, The Journal of Immunology.

[58]  E. Shevach,et al.  The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells , 2006, Immunological reviews.

[59]  Jean Imbert,et al.  Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. , 2006, Cytokine & growth factor reviews.

[60]  C. Tomlin,et al.  Biology by numbers: mathematical modelling in developmental biology , 2007, Nature Reviews Genetics.

[61]  J. Rogers,et al.  Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity , 2007, Nature Genetics.

[62]  Cristina M. Tato,et al.  Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals , 2007, The Journal of experimental medicine.

[63]  Melissa L. Kemp,et al.  Quantitative Network Signal Combinations Downstream of TCR Activation Can Predict IL-2 Production Response1 , 2007, The Journal of Immunology.

[64]  J. Todd,et al.  Association of the interleukin‐2 receptor alpha (IL‐2Rα)/CD25 gene region with Graves’ disease using a multilocus test and tag SNPs , 2007, Clinical endocrinology.

[65]  S. Ishihara,et al.  CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells , 2007, Nature Immunology.

[66]  J. Bluestone,et al.  Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. , 2008, Immunity.

[67]  A. Rudensky,et al.  Coordination of Early Protective Immunity to Viral Infection by Regulatory T Cells , 2008, Science.

[68]  R. Germain,et al.  Variability and Robustness in T Cell Activation from Regulated Heterogeneity in Protein Levels , 2008, Science.

[69]  A. Scheffold,et al.  IL‐2 induces in vivo suppression by CD4+CD25+Foxp3+ regulatory T cells , 2008, European journal of immunology.

[70]  J. Sprent,et al.  In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression , 2009, The Journal of experimental medicine.

[71]  S. Sakaguchi,et al.  Regulatory T cells: how do they suppress immune responses? , 2009, International immunology.

[72]  Andreas Radbruch,et al.  Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12. , 2009, Immunity.

[73]  S. Holland,et al.  Analysis of Adhesion Molecules, Target Cells, and Role of IL-2 in Human FOXP3+ Regulatory T Cell Suppressor Function1 , 2009, The Journal of Immunology.

[74]  E. Shevach Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[75]  Peter O. Krutzik,et al.  The Initial Phase of an Immune Response Functions to Activate Regulatory T Cells1 , 2009, The Journal of Immunology.

[76]  Dorothea Busse,et al.  Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments , 2010, Proceedings of the National Academy of Sciences.

[77]  J. Thèze,et al.  IL-2 induces conformational changes in its preassembled receptor core, which then migrates in lipid raft and binds to the cytoskeleton meshwork. , 2010, Journal of molecular biology.

[78]  The Initial Phase , 2011 .

[79]  Stephen T. C. Wong,et al.  Coordination of Early Protective Immunity to Viral Infection by Regulatory T Cells , 2022 .